Inhibition of NIMA-related kinase 2 (NEK2) enhances the sensitivity of GC cells to RSL3 and erastin-induced ferroptosis [21]
Luthione delivers glutathione directly into the body through IV (vein) infusion or IM (muscle) injection
The clinician can compare injured and uninjured structures on contralateral sides of the body, follow the path of long bodies like nerves, muscles, bones and fascia, and explore how movement in one area impacts structures further along the kinetic chain
Glutathione conjugates with heavy metals and toxins helping the body to eliminate these harmful substances
Reactive oxygen species-dependent c-Jun NH2-terminal kinase/c-Jun signaling cascade mediates neuroblastoma cell death induced by diallyl disulfide
Advances in Glutathione Research for Disease Research Targeted therapy for GSH metabolism has become a research hotspot, and metabolomics and proteomics technologies have also provided powerful tools for GSH-related research: Targeting GSH metabolism : Inhibiting key molecules such as GCLC, xCT (cysteine uptake carrier) or SLC25A39 (mitochondrial GSH transporter), or using GSH-depleting nanozymes, has shown the potential to enhance ROS-mediated tumor cell death and improve related disease symptoms in preclinical models (such as cell models and animal models), providing new strategies for disease treatment
